Capstone Investment Advisors’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$82.9K Hold
51,190
﹤0.01% 1549
2025
Q4
$144K Hold
51,190
﹤0.01% 1519
2025
Q3
$105K Hold
51,190
﹤0.01% 1872
2025
Q2
$161K Hold
51,190
﹤0.01% 1542
2025
Q1
$161K Hold
51,190
﹤0.01% 1281
2024
Q4
$222K Hold
51,190
﹤0.01% 1566
2024
Q3
$137K Hold
51,190
﹤0.01% 1669
2024
Q2
$114K Hold
51,190
﹤0.01% 1870
2024
Q1
$273K Hold
51,190
﹤0.01% 1879
2023
Q4
$75.8K Hold
51,190
﹤0.01% 1968
2023
Q3
$71.2K Hold
51,190
﹤0.01% 1986
2023
Q2
$75.2K Hold
51,190
﹤0.01% 1732
2023
Q1
$84.5K Hold
51,190
﹤0.01% 1391
2022
Q4
$71.7K Hold
51,190
﹤0.01% 1431
2022
Q3
$79K Hold
51,190
﹤0.01% 1586
2022
Q2
$113K Hold
51,190
﹤0.01% 1486
2022
Q1
$127K Hold
51,190
﹤0.01% 1823
2021
Q4
$308K Sell
51,190
-1,159
-2% -$6.91K ﹤0.01% 1525
2021
Q3
$349K Buy
52,349
+1,159
+2% +$7.28K ﹤0.01% 1622
2021
Q2
$340K Sell
51,190
-6,030
-11% -$51.1K ﹤0.01% 1443
2021
Q1
$530K Sell
57,220
-67,568
-54% -$821K ﹤0.01% 1255
2020
Q4
$2.25M Buy
+124,788
New +$2.19M 0.01% 839

Other funds holding CRDF